Gary Gamboa (B.S. Microbiology, Indiana University, Bloomington, Indiana) joined Eli Lilly & Company in 1986 as a biologist supporting molecular biology research. In 1990, he joined Parenteral Manufacturing organization where he has since served in various Technical Services/Manufacturing Sciences roles. From his initial time providing floor technical support to more recent responsibilities of new product commercialization, he has developed and executed strategies for product technology transfer, commercialization, control strategy, and process validation. He has performed global transfers of products within Lilly and to contract manufacturers and has been involved with a lifecycle stewardship role for several legacy drug products. His colleagues call upon his extensive experience with Parenteral manufacturing and his recent role involves commercialization of monoclonal antibody biomolecule drug products.